PhRMA study reveals 313 mental illness drugs now in R&D
07/19/10
News
A new study by the Pharmaceutical Research and Manufacturers of America (PhRMA) reveals that 313 new medicines to treat mental health disorders are now either in clinical trial or awaiting FDA review.